State Street’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.1M | Buy |
1,297,323
+195,431
| +18% | +$3.46M | ﹤0.01% | 2217 |
|
|
2025
Q4 | $20.6M | Buy |
1,101,892
+45,987
| +4% | +$763K | ﹤0.01% | 2257 |
|
|
2025
Q3 | $15.4M | Buy |
1,055,905
+20,257
| +2% | +$256K | ﹤0.01% | 2380 |
|
|
2025
Q2 | $11.4M | Sell |
1,035,648
-31,127
| -3% | -$303K | ﹤0.01% | 2511 |
|
|
2025
Q1 | $9.53M | Sell |
1,066,775
-155,695
| -13% | -$1.45M | ﹤0.01% | 2551 |
|
|
2024
Q4 | $11.5M | Buy |
1,222,470
+30,849
| +3% | +$281K | ﹤0.01% | 2544 |
|
|
2024
Q3 | $9.6M | Sell |
1,191,621
-75,754
| -6% | -$656K | ﹤0.01% | 2632 |
|
|
2024
Q2 | $10.7M | Sell |
1,267,375
-101,406
| -7% | -$915K | ﹤0.01% | 2518 |
|
|
2024
Q1 | $12.3M | Sell |
1,368,781
-21,533
| -2% | -$200K | ﹤0.01% | 2453 |
|
|
2023
Q4 | $15.6M | Sell |
1,390,314
-80,873
| -5% | -$814K | ﹤0.01% | 2333 |
|
|
2023
Q3 | $12.7M | Sell |
1,471,187
-6,101
| -0.4% | -$58.9K | ﹤0.01% | 2444 |
|
|
2023
Q2 | $15.3M | Buy |
1,477,288
+66,280
| +5% | +$732K | ﹤0.01% | 2410 |
|
|
2023
Q1 | $15.3M | Sell |
1,411,008
-21,911
| -2% | -$232K | ﹤0.01% | 2406 |
|
|
2022
Q4 | $16.1M | Sell |
1,432,919
-51,840
| -3% | -$545K | ﹤0.01% | 2397 |
|
|
2022
Q3 | $15.1M | Sell |
1,484,759
-10,287
| -0.7% | -$96.4K | ﹤0.01% | 2434 |
|
|
2022
Q2 | $13.5M | Sell |
1,495,046
-46,487
| -3% | -$428K | ﹤0.01% | 2512 |
|
|
2022
Q1 | $14.7M | Buy |
1,541,533
+181,331
| +13% | +$1.78M | ﹤0.01% | 2601 |
|
|
2021
Q4 | $15M | Sell |
1,360,202
-12,045
| -0.9% | -$105K | ﹤0.01% | 2666 |
|
|
2021
Q3 | $10.2M | Buy |
1,372,247
+116,189
| +9% | +$1.3M | ﹤0.01% | 2881 |
|
|
2021
Q2 | $18.2M | Buy |
1,256,058
+103,439
| +9% | +$1.94M | ﹤0.01% | 2572 |
|
|
2021
Q1 | $23.5M | Buy |
1,152,619
+103,274
| +10% | +$1.96M | ﹤0.01% | 2264 |
|
|
2020
Q4 | $18.6M | Sell |
1,049,345
-42,339
| -4% | -$760K | ﹤0.01% | 2278 |
|
|
2020
Q3 | $16.1M | Sell |
1,091,684
-14,147
| -1% | -$265K | ﹤0.01% | 2154 |
|
|
2020
Q2 | $23.2M | Buy |
1,105,831
+50,563
| +5% | +$1.3M | ﹤0.01% | 1947 |
|
|
2020
Q1 | $24.4M | Buy |
1,055,268
+95,704
| +10% | +$2.4M | ﹤0.01% | 1723 |
|
|
2019
Q4 | $24.8M | Buy |
959,564
+11,948
| +1% | +$232K | ﹤0.01% | 1992 |
|
|
2019
Q3 | $18.5M | Buy |
947,616
+9,112
| +1% | +$184K | ﹤0.01% | 2107 |
|
|
2019
Q2 | $15.3M | Buy |
938,504
+34,750
| +4% | +$704K | ﹤0.01% | 2270 |
|
|
2019
Q1 | $20.5M | Buy |
903,754
+22,108
| +3% | +$561K | ﹤0.01% | 2025 |
|
|
2018
Q4 | $22.6M | Sell |
881,646
-2,152
| -0.2% | -$58.1K | ﹤0.01% | 1896 |
|
|
2018
Q3 | $28.9M | Buy |
883,798
+6,405
| +0.7% | +$175K | ﹤0.01% | 1922 |
|
|
2018
Q2 | $19.9M | Buy |
877,393
+15,942
| +2% | +$379K | ﹤0.01% | 2134 |
|
|
2018
Q1 | $20.9M | Sell |
861,451
-21,645
| -2% | -$594K | ﹤0.01% | 2027 |
|
|
2017
Q4 | $24.6M | Sell |
883,096
-30,740
| -3% | -$910K | ﹤0.01% | 1901 |
|
|
2017
Q3 | $31.3M | Buy |
913,836
+24,154
| +3% | +$790K | ﹤0.01% | 1700 |
|
|
2017
Q2 | $35.4M | Buy |
889,682
+19,428
| +2% | +$747K | ﹤0.01% | 1582 |
|
|
2017
Q1 | $32M | Buy |
870,254
+19,230
| +2% | +$614K | ﹤0.01% | 1604 |
|
|
2016
Q4 | $27.1M | Buy |
851,024
+131,646
| +18% | +$4.08M | ﹤0.01% | 1671 |
|
|
2016
Q3 | $26.1M | Buy |
719,378
+9,807
| +1% | +$273K | ﹤0.01% | 1597 |
|
|
2016
Q2 | $16.1M | Buy |
709,571
+165,364
| +30% | +$3.57M | ﹤0.01% | 1914 |
|
|
2016
Q1 | $10.2M | Buy |
544,207
+15,574
| +3% | +$255K | ﹤0.01% | 2157 |
|
|
2015
Q4 | $8.66M | Sell |
528,633
-254,231
| -32% | -$4.03M | ﹤0.01% | 2269 |
|
|
2015
Q3 | $8.61M | Sell |
782,864
-80,414
| -9% | -$1.02M | ﹤0.01% | 2249 |
|
|
2015
Q2 | $11.2M | Sell |
863,278
-141,631
| -14% | -$2.2M | ﹤0.01% | 2196 |
|
|
2015
Q1 | $17.4M | Buy |
1,004,909
+44,749
| +5% | +$820K | ﹤0.01% | 1927 |
|
|
2014
Q4 | $14.3M | Sell |
960,160
-151,877
| -14% | -$2.65M | ﹤0.01% | 1999 |
|
|
2014
Q3 | $25.6M | Buy |
1,112,037
+517,179
| +87% | +$15M | ﹤0.01% | 1555 |
|
|
2014
Q2 | $19M | Buy |
+594,858
| New | +$17.9M | ﹤0.01% | 1836 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
State Street's TBPH Position: Q1 2026 in Review
State Street increased its Theravance Biopharma (TBPH) stake by 18% in Q1 2026, buying an estimated $3.46M and bringing the position to 1,297,323 shares worth $21.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.
State Street first reported a position in TBPH in Q2 2014 and has held it in 48 quarters since. The position peaked at $35.4M in Q2 2017. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.
- State Street held 1,297,323 shares of Theravance Biopharma worth $21.1M as of Q1 2026.
- State Street bought 195,431 Theravance Biopharma shares in Q1 2026, an estimated $3.46M.
- Theravance Biopharma made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2217 holding.
- State Street first reported a position in Theravance Biopharma in Q2 2014 and has held it in 48 quarters since.
- State Street's Theravance Biopharma position peaked at $35.4M in Q2 2017.
- 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.